ANRO Alto Neuroscience, Inc.
Alto Neuroscience, Inc. (ANRO) Hedge Fund Activity
This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.
Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.
Most significant moves
Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.
| Fund | Action | Shares changed | Change | Est. value | Portfolio wt. | Score |
|---|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. Quant | Sold Out | -45.3K | -100.0% | $1.2M | 0.0% | 60 |
| Balyasny Asset Management L.P. | Sold Out | -32.1K | -100.0% | $847.4K | 0.0% | 57 |
| Qube Research & Technologies Ltd Quant | Sold Out | -209.3K | -100.0% | $5.5M | 0.0% | 57 |
| Hudson Bay Capital Management Event | Sold Out | -43.8K | -100.0% | $1.2M | 0.0% | 55 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Increased | +1.22M | +315.6% | $32.1M | 0.1% | 54 |
| Vestal Point Capital Growth Healthcare | Reduced | -1.28M | -62.0% | $33.8M | 0.5% | 53 |
| Schonfeld Strategic Advisors Long/Short Quant | New | +257.6K | — | $6.8M | 0.0% | 53 |
| Brevan Howard Capital Management Macro | Sold Out | -38.8K | -100.0% | $1.0M | 0.0% | 51 |
| Affinity Asset Advisors Long/Short Growth | Increased | +350.0K | +70.0% | $9.2M | 1.1% | 49 |
| Y-Intercept Quant | Sold Out | -23.9K | -100.0% | $631.9K | 0.0% | 48 |
Most significant buyers
By move score, not size.
- ADAGE CAPITAL PARTNERS GP, L.L.C.
- Schonfeld Strategic Advisors
- Affinity Asset Advisors
- OrbiMed Advisors
- MARSHALL WACE, LLP
Most significant sellers
By move score, not size.
- D. E. Shaw & Co., Inc.
- Balyasny Asset Management L.P.
- Qube Research & Technologies Ltd
- Hudson Bay Capital Management
- Vestal Point Capital
Hedge fund positions
| Fund | Tier | Shares | Previous | Change | Change % | Portfolio wt. | Action | Score |
|---|---|---|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 1 | 0 | 45.3K | -45.3K | -100.0% | 0.0% | Sold Out | 60 |
| Balyasny Asset Management L.P. | 2 | 0 | 32.1K | -32.1K | -100.0% | 0.0% | Sold Out | 57 |
| Qube Research & Technologies Ltd | 2 | 0 | 209.3K | -209.3K | -100.0% | 0.0% | Sold Out | 57 |
| Hudson Bay Capital Management | 3 | 0 | 43.8K | -43.8K | -100.0% | 0.0% | Sold Out | 55 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2 | 1.6M | 385.0K | +1.22M | +315.6% | 0.1% | Increased | 54 |
| Vestal Point Capital | 1 | 785.0K | 2.1M | -1.28M | -62.0% | 0.5% | Reduced | 53 |
| Schonfeld Strategic Advisors | 3 | 257.6K | 0 | +257.6K | — | 0.0% | New | 53 |
| Brevan Howard Capital Management | 3 | 0 | 38.8K | -38.8K | -100.0% | 0.0% | Sold Out | 51 |
| Affinity Asset Advisors | 2 | 850.0K | 500.0K | +350.0K | +70.0% | 1.1% | Increased | 49 |
| Y-Intercept | 4 | 0 | 23.9K | -23.9K | -100.0% | 0.0% | Sold Out | 48 |
| Alkeon Capital Management | 1 | 102.1K | 227.1K | -125.0K | -55.0% | 0.0% | Reduced | 46 |
| Perceptive Advisors | 1 | 1.6M | 2.0M | -400.0K | -19.9% | 0.7% | Reduced | 43 |
| OrbiMed Advisors | 2 | 257.9K | 167.5K | +90.4K | +53.9% | 0.1% | Increased | 42 |
| MILLENNIUM MANAGEMENT LLC | 2 | 558.3K | 822.0K | -263.7K | -32.1% | 0.0% | Reduced | 36 |
| TWO SIGMA INVESTMENTS, LP | 2 | 147.3K | 216.1K | -68.8K | -31.8% | 0.0% | Reduced | 36 |
| RENAISSANCE TECHNOLOGIES LLC | 1 | 71.4K | 103.5K | -32.1K | -31.0% | 0.0% | Reduced | 35 |
| MARSHALL WACE, LLP | 2 | 225.5K | 176.3K | +49.2K | +27.9% | 0.0% | Increased | 34 |
| Squarepoint Ops LLC | 2 | 21.3K | 30.0K | -8.7K | -29.0% | 0.0% | Reduced | 31 |
| Point72 Asset Management, L.P. | 1 | 503.0K | 503.1K | -137 | -+0.0% | 0.0% | Reduced | 28 |
| Armistice Capital | 3 | 864.0K | 912.0K | -48.0K | -5.3% | 0.6% | Reduced | 28 |
| Boothbay Fund Management | 4 | 106.2K | 139.3K | -33.1K | -23.7% | 0.1% | Reduced | 24 |
| Alpha Wave Global | 1 | 3.7M | 3.7M | 0 | +0.0% | 1.6% | Unchanged | 49 |
| Integral Health Asset Management | 2 | 500.0K | 500.0K | 0 | +0.0% | 0.5% | Unchanged | 23 |
Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeHedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.